This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08139/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08139/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08139/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08139/identifier/pubchem-substance/
n5http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/drug/DB08139/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08139
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB08139 n10:DB08139
dcterms:title
5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile
adms:identifier
n4:DB08139 n11:99444610 n12:LZB n13:24971312 n14:22377576
n5:IUPAC-Name
n6:271B6203-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6209-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6208-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6205-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6206-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6207-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B6201-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B61FF-363D-11E5-9242-09173F13E4C5 n6:271B6202-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6200-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B620F-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6210-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B620A-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B620B-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B620D-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B620C-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B620E-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6214-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6216-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6217-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6213-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6212-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6215-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6204-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6211-363D-11E5-9242-09173F13E4C5